# Clinical trials recruiting in Vermont: 215 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 215 trials recruiting or not yet recruiting with a site in Vermont, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Vermont: 215 rows for $10.75, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/state/vermont

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 215
- Recruiting or not yet: 215
- Read on: November 19, 2026

## Trials

The 25 newest of 215, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| September 24, 2026 | NCT07840118 | Smartphone-based Incentives Intervention to Increase Smoking Cessation During Pregnancy | University of Vermont | Not applicable | Not yet recruiting | Smoking During Pregnancy and Postpartum, Perinatal Cigarette Smoking | 137 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07840118) |
| September 21, 2026 | NCT07830732 | A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A | Novo Nordisk A/S | Phase 3 | Recruiting | Haemophilia A | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07830732) |
| August 31, 2026 | NCT07795255 | Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (CystoDiscomfort) | Sponsor not shown (see the record) | Phase 3 | Not yet recruiting | Bladder (Urothelial, Transitional Cell) Cancer, Hematuria | 1,740 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07795255) |
| August 25, 2026 | NCT07783607 | MM-CARE: Cardiovascular Risk Assessment in Adults With Multiple Myeloma | University of Vermont Medical Center | Not applicable | Not yet recruiting | Multiple Myeloma, Heart Disease Risk Factors | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07783607) |
| August 20, 2026 | NCT07775495 | Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure | Ecotera Health LLC | Observational | Recruiting | Healthy Adult Participants | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07775495) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| July 31, 2026 | NCT07739576 | Descriptions and Practices of Family Engagement in Emergency Care Setting | Mayo Clinic | Observational | Recruiting | Emergency Care | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07739576) |
| June 17, 2026 | NCT07652658 | A Phase IIb Study to Evaluate AZD8965 in Participants With IPF. | AstraZeneca | Phase 2 | Recruiting | Idiopathic Pulmonary Fibrosis (IPF) | 359 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652658) |
| May 29, 2026 | NCT07615049 | Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation | SWOG Cancer Research Network | Phase 3 | Recruiting | Recurrent Soft Tissue Sarcoma of the Trunk and Extremities, Resectable Soft Tissue Sarcoma of the Trunk and... | 296 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615049) |
| May 27, 2026 | NCT07609108 | Pridopidine Phase 3 Study in Huntington's Disease | Prilenia | Phase 3 | Recruiting | Huntington Disease | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609108) |
| May 18, 2026 | NCT07592689 | A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend) | Definium Therapeutics US, Inc. | Phase 3 | Recruiting | Major Depressive Disorder | 165 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07592689) |
| March 30, 2026 | NCT07500506 | A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth Dose of 6-Valent OspA-Based Lyme Disease Vaccine | Pfizer | Phase 3 | Recruiting | Lyme Disease | 1,712 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07500506) |
| March 17, 2026 | NCT07477418 | PDAC Regression and Intraoperative Surgical Margin With Neoadjuvant TAMP (PRISM-TAMP) | University of Vermont | Phase 1/2 | Not yet recruiting | Pancreatic Ductal Adenocarcinoma (PDAC), Borderline Resectable Pancreatic Cancer, Pancreatic Neoplasms | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07477418) |
| February 27, 2026 | NCT07440641 | RE-FIT (Remote Exercise for Physical Function in WTC Responders With Prostate Cancer) | University of Vermont | Not applicable | Not yet recruiting | Prostate Cancer | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07440641) |
| February 13, 2026 | NCT07408830 | VA Randomized Trial of Surveillance Intervals After Transurethral Resection of High Grade Bladder Tumors | VA Office of Research and Development | Not applicable | Not yet recruiting | High-Grade Early-Stage Bladder Cancer | 2,482 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408830) |
| February 12, 2026 | NCT07406594 | Gut Microbiome Changes During Abemaciclib Therapy in Breast Cancer | University of Vermont Medical Center | Not applicable | Not yet recruiting | Breast Cancer, HER-2 Positive Breast Cancer | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07406594) |
| February 6, 2026 | NCT07393555 | Treatment for Advanced Non-small Cell Lung Cancer With Actionable Genomic Alterations After Targeted Treatment and Chemotherapy (An... | SWOG Cancer Research Network | Phase 2 | Recruiting | Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | 117 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07393555) |
| February 4, 2026 | NCT07385677 | Comparing the Effectiveness of the 'Think in Nerve Length and Layers' (TINLL) Approach to Traditional Treatment for Patients With Lateral... | University of Vermont | Not applicable | Recruiting | Lateral Elbow Tendinopathy (Tennis Elbow) | 68 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07385677) |
| January 22, 2026 | NCT07359846 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359846) |
| January 13, 2026 | NCT07336251 | Transcranial Magnetic Stimulation in Veterans With PTSD | White River Junction Veterans Affairs Medical Center | Not applicable | Recruiting | PTSD - Post Traumatic Stress Disorder | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336251) |
| January 13, 2026 | NCT07335614 | Evaluation of Protein Loading on Measurement of Renal Reserve | MediBeacon | Not applicable | Not yet recruiting | Glomerular Filtration Rate | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07335614) |
| January 9, 2026 | NCT07330258 | A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's... | Bayer | Observational | Recruiting | Parkinson's Disease | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07330258) |
| January 8, 2026 | NCT07326709 | A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease | Novartis Pharmaceuticals | Phase 3 | Recruiting | Huntington Disease | 770 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07326709) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| University of Vermont Medical Center | Burlington | 79 |
| University of Vermont and State Agricultural College | Burlington | 52 |
| Dartmouth Cancer Center - North | Saint Johnsbury | 32 |
| University of Vermont | Burlington | 32 |
| Central Vermont Medical Center/National Life Cancer Treatment | Berlin Corners | 25 |
| The University of Vermont Medical Center | Burlington | 10 |
| The University of Vermont Medical Center Inc. | Burlington | 6 |
| White River Junction Veteran Administration Medical Center | White River Junction | 4 |
| White River Junction VA Medical Center, White River Junction, VT | White River Junction | 3 |
| The Memory Clinic | Bennington | 2 |
| White River Junction Veterans Healthcare System | White River Junction | 2 |
| Norris Cotton Cancer Center-North | Saint Johnsbury | 1 |
| The University of Vermont MC | Burlington | 1 |
| UVM Larner College of Medicine MMG/VCT | Burlington | 1 |
| Vermont Regional Cancer Center | Burlington | 1 |
| Mount Ascutney Hospital | Windsor | 1 |
| Neuropsychiatric Associates, Plc | Woodstock | 1 |
| Orthopedica and Rehabilitation Center - Occupational Therapy/Hand Therapy, University of Vermont Medical Center | South Burlington | 1 |
| University of Vermont Cancer Center | Burlington | 1 |
| University of Vermont Medical Centre | Burlington | 1 |
| University of Vermount and Sate Agricultural College | Burlington | 1 |
| White River Junction Veterans Affairs Medical Center, Primary Care Clinic | White River Junction | 1 |
| White River Junction Veterans Affairs Medical Center, VA Mailed FIT Program | White River Junction | 1 |
| University of Vemont | Burlington | 1 |
| White River Junction VA Hospital | White River Junction | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 5 |
| Phase 1/2 | 1 |
| Phase 2 | 43 |
| Phase 2/3 | 9 |
| Phase 3 | 82 |
| Phase 4 | 3 |
| Not applicable | 39 |
| Observational | 33 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Heart Failure | 9 |
| Lung Neoplasms | 8 |
| Carcinoma, Non-Small-Cell Lung | 8 |
| Leukemia, Myeloid, Acute | 7 |
| Neoplasms | 7 |
| Prostatic Neoplasms | 6 |
| Breast Neoplasms | 6 |
| Colorectal Neoplasms | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Pancreatic Neoplasms | 5 |
| Leukemia | 5 |
| Cardiovascular Diseases | 5 |
| Urinary Bladder Neoplasms | 5 |
| Melanoma | 5 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Mouth Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Parkinson Disease | 4 |
| Lung Diseases | 4 |
| Cystic Fibrosis | 4 |
| Oropharyngeal Neoplasms | 3 |
| Hypopharyngeal Neoplasms | 3 |
| Carcinoma | 3 |
| Laryngeal Neoplasms | 3 |
| Carcinoma, Renal Cell | 3 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| National Cancer Institute (NCI) | 22 |
| University of Vermont | 17 |
| SWOG Cancer Research Network | 12 |
| University of Vermont Medical Center | 12 |
| Alliance for Clinical Trials in Oncology | 12 |
| NRG Oncology | 10 |
| Children's Oncology Group | 10 |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 9 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 6 |
| Canadian Cancer Trials Group | 5 |
| Johns Hopkins University | 3 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 3 |
| ECOG-ACRIN Cancer Research Group | 3 |
| [Genzyme, a Sanofi Company](https://specstream.ai/data/clinical-trials/company/genzyme-a-sanofi-company) | 3 |
| VA Office of Research and Development | 3 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 2 |
| Dartmouth-Hitchcock Medical Center | 2 |
| Duke University | 2 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 2 |
| [Medtronic](https://specstream.ai/data/clinical-trials/company/medtronic) | 2 |
| Mayo Clinic | 2 |
| University of Rochester | 2 |
| Colorado Prevention Center | 2 |
| White River Junction Veterans Affairs Medical Center | 2 |
| Kura Oncology, Inc. | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in Vermont

- [Financial services firms in Vermont, United States](https://specstream.ai/data/businesses/financial-services-firms/vermont-united-states)
- [Web design firms in Vermont, United States](https://specstream.ai/data/businesses/web-design-firms/vermont-united-states)
- [Landscaping companies in Vermont, United States](https://specstream.ai/data/businesses/landscaping-companies/vermont-united-states)
- [Broadcast media production companies in Vermont, United States](https://specstream.ai/data/businesses/broadcast-media-production-companies/vermont-united-states)
- [Pediatric clinics in Vermont, United States](https://specstream.ai/data/businesses/pediatric-clinics/vermont-united-states)
- [Diners in Vermont, United States](https://specstream.ai/data/businesses/diners/vermont-united-states)
